Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
24 April, 2024 18:56 IST
IDBI Capital maintains Accumulate on TCS with target of Rs 3,530
Source: IRIS | 14 Apr, 2021, 12.31PM
Rating: NAN / 5 stars.
Comments  |  Post Comment

 TCS reported a third consecutive quarter of all-round performance in Q4FY21. Revenue grew by 4.2% QoQ in CC (3rd consecutive quarter of 4%+ QoQ growth), higher than our forecast of +3%. However, EBIT margin improvement of ~20bps QoQ to 26.8% was slightly lower than our forecast of 27.3%, said IDBI Capital in its report.

In Q4FY21, TCS has secured deals with an all-time high TCV of USD 9.2 billion taking the FY21 TCV to USD 31.6 billion, +17% YoY. TCS has maintained its positive outlook and is confident of achieving a double-digit YoY revenue growth in CC for FY22.

Post Q4 earnings, IDBI Capital said,  "We fine-tune our forecast of revenue/EPS CAGR of 11.8%/14.4% over FY21-23. We maintain 'Accumulate' and TP to Rs 3,530 based on PER of 30x FY23E.

Disclaimer: IRIS has taken due care and caution in compilation of data for its web site. Information has been obtained by IRIS from sources which it considers reliable. However, IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website.

 



 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer